Novavax Inc. plans to sell up to $75 million of its common shares from time to time in at-the-market offering.
B. Riley FBR Inc. is acting as the sales agent for the offering.
Novavax plans to sell $75M of common stock
Gauging Supply Chain Risk In Volatile Times
Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals
The Future of Risk Management Digitization in Credit Risk Management
Climate Credit Analytics: Diving into the model
Novavax plans to sell $75M of common stock
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals
- Author
- Mirza Salam Ahmed
- Theme
- Healthcare & Pharmaceuticals